New Nonsegmental Vitiligo Study

New Nonsegmental Vitiligo Study

Now Enrolling in West Palm Beach, Florida

A nonsegmental vitiligo clinical study is now enrolling in West Palm Beach, FL.  Researchers are evaluating the safety and effectiveness of an investigational gel in the treatment of Non-Segmental Vitiligo.  For more information, or to see if you qualify to participate in this study, call Metabolic Research Institute Inc. (561) 802-3060, ext. 8036 or visit:  https://www.metabolic-institute.com/vitiligo-study/

Type 1 Diabetes Trial

Enrolling Now in West Palm Beach Florida

For adults with Type 1 Diabetes, this clinical research study may be of interest to you.  The purpose of the study is to evaluate the safety and effectiveness of an investigational oral medication in managing glucose levels in the treatment of Type 1 Diabetes.

High Blood Pressure and Chronic Kidney Disease

High Blood Pressure and Chronic Kidney Disease

Clinical Research Study Enrolling Now in West Palm Beach, FL

Researchers are evaluating the safety and effectiveness of an oral investigational drug for people with high blood pressureand chronic kidney disease.

Health insurance is not necessary to participate in the study.

For more information, call Metabolic Research Institute Inc. (561) 802-3060, ext. 8036 or visit: https://www.metabolic-institute.com/CKD

Nonsegmental Vitiligo Study

New Vitiligo Study – Now Enrolling
West Palm Beach, Florida

New research study enrolling in West Palm Beach, FL for people who have nonsegmental vitiligo (white patches of skin) on the face and body.

Researchers are testing an investigational oral medication.

• Study-related care from local doctors

• For adults 18 years of age or older

www.metabolic-institute.com/vitiligo/

Metabolic Research Institute Inc.

1515 N Flagler Dr # 440, West Palm Beach FL

561-802-3060, ext. 8036

Concerned about fatty liver?

Fatty Liver Disease (NASH) Clinical Research Study
Enrolling Now in West Palm Beach FL

The SYNCHRONY Histology study is a clinical study to see what effect an investigational drug, EFX, has on scarring of the liver in NASH. AII participants will need to have NASH shown in a liver biopsy (sample of liver tissue). The biopsy may be obtained previously (within 180 days of screening visit), or during the screening process.

We are looking for adults 18 – 80 years of age who have been diagnosed with fatty liver (NASH) and fibrosis. The clinical research study will evaluate the safety and effectiveness of an investigational drug on scarring of the liver in NASH.

For more information, or to see if you qualify to participate in this study, call Metabolic Research Institute Inc. (561) 802-3060, ext. 8036 or visit: www.metabolic-institute.com/nash-clinical-trial/

DM2 on Metformin

Clinical study enrolling now in West Palm Beach, FL

ACHIEVE – 3

ACHIEVE-3 is a clinical research study for people with Type 2 Diabetes who are being treated with metformin.

The study will test if an investigational medicine (the medicine being studied) can help with blood glucose (sugar) and weight management compared with an existing treatment for Type 2 diabetes.

For more information, or to see if you qualify to participate in this study, please call Metabolic Research Institute Inc. (561) 802-3060, ext. 8036 or visit:  https://www.metabolic-institute.com/dm2-on-metformin.